Advanced Enzyme Technologies Limited
Bombay Stock ExchangeTotal Valuation
Advanced Enzyme Technologies Limited carries a market capitalization of 35.92B, placing it among publicly traded companies globally. Its enterprise value stands at 22.32B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 35.92B |
| Enterprise Value | 22.32B |
Share Statistics
Advanced Enzyme Technologies Limited currently has 111.93M shares outstanding.
| Shares Outstanding | 111.93M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Advanced Enzyme Technologies Limited trades at a trailing price-to-earnings ratio of 16.94. The price-to-sales ratio is 3.83, and the price-to-book ratio stands at 127.65.
| PE Ratio | 16.94 |
| PS Ratio | 3.83 |
| PB Ratio | 127.65 |
| P/TBV Ratio | 2.26 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Advanced Enzyme Technologies Limited trades at an EV/EBITDA multiple of 11.81 and an EV/FCF ratio of 1,138.16. The EV/Sales ratio of 2.99 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 11.81 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.99 |
| EV / EBITDA | 11.81 |
| EV / EBIT | 11.81 |
| EV / FCF | 1,138.16 |
Financial Position
Advanced Enzyme Technologies Limited maintains a current ratio of 9.78, meaning it holds 9.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.90, indicating elevated leverage, while an interest coverage ratio of 71.93 demonstrates strong ability to service its debt obligations.
| Current Ratio | 9.78 |
| Quick Ratio | 6.64 |
| Debt / Equity | 1.90 |
| Debt / EBITDA | 0.17 |
| Interest Coverage | 71.93 |
Financial Efficiency
Advanced Enzyme Technologies Limited posts a return on equity of 28.17 and a return on invested capital of 8.74.
| Return on Equity (ROE) | 28.17 |
| Return on Assets (ROA) | 9.75 |
| Return on Invested Capital (ROIC) | 8.74 |
| Return on Capital Employed (ROCE) | 24.24 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.15 |
Taxes
Over the trailing twelve months, Advanced Enzyme Technologies Limited has paid 589.28M in income taxes, reflecting an effective tax rate of 25.34.
| Income Tax | 589.28M |
| Effective Tax Rate | 25.34 |
Stock Price Statistics
Advanced Enzyme Technologies Limited's stock has declined approximately -4.9889% over the past 52 weeks. The 50-day moving average sits at 361.66, while the 200-day moving average is 316.28.
| Beta (5Y) | N/A |
| 52-Week Price Change | -4.9889% |
| 50-Day Moving Average | 361.66 |
| 200-Day Moving Average | 316.28 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Advanced Enzyme Technologies Limited generated 7.46B in revenue and converted that into 1.69B in net income, yielding earnings per share of 15.51. EBITDA reached 1.89B, while operating income came in at 1.89B.
| Revenue | 7.46B |
| Gross Profit | 5.53B |
| Operating Income | 1.89B |
| Pretax Income | 2.33B |
| Net Income | 1.69B |
| EBITDA | 1.89B |
| EBIT | 1.89B |
| Earnings Per Share (EPS) | 15.51 |
Balance Sheet
Advanced Enzyme Technologies Limited holds 7.08B in cash and equivalents against 320.09M in total debt, resulting in a net debt position of -882.27M. Total book value stands at 223.85M, with working capital of 9.37B providing operational flexibility.
| Cash & Cash Equivalents | 7.08B |
| Total Debt | 320.09M |
| Net Debt | -882.27M |
| Equity (Book Value) | 223.85M |
| Book Value Per Share | 2.00 |
| Working Capital | 9.37B |
Margins
Advanced Enzyme Technologies Limited operates with a gross margin of 74.13, reflecting its pricing power and cost economics. The operating margin of 25.34 and net profit margin of 22.62 provide insight into operational efficiency.
| Gross Margin | 74.13 |
| Operating Margin | 25.34 |
| Pretax Margin | 31.18 |
| Profit Margin | 22.62 |
| EBITDA Margin | 25.34 |
Stock Splits
Advanced Enzyme Technologies Limited's most recent stock split took place on May 25, 2017 with a 1:5 split ratio.
| Last Split Date | 5/25/2017 |
| Split Ratio | 1:5 |
Scores
Advanced Enzyme Technologies Limited posts an Altman Z-Score of 12.77, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 12.77 |